Skip to main content
In stock|Cellular Therapy

Remestemcel-L

Oncology TypeHematologic
Drug Class / MechanismAllogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Therapy
No Image
Description

Remestemcel-L is classified as an Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Therapy, sourced for use within our Cellular Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryCellular Therapy
Oncology TypeHematologic

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3